NCT01295398Unknown不适用
Influence of the Nebulizer on the Clinical Efficacy of Hypertonic Saline 3% in Children Aged Less Than 18 Months and Hospitalized With Acute Viral Bronchiolitis
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 168
- 试验地点
- 2
- 主要终点
- the improvement of the clinical score of severity at the 48th hour between the 3 groups of children
研究概览
简要总结
The aim of the investigators study is to compare in children aged less than 18 months and hospitalized for an acute viral bronchiolitis the efficacy of the HS 3% (Mucoclear®, sterile ampoules of 4 ml) nebulised with a conventional jet-nebulizer (particles diameter of 4-5 µm), or with a jet-nebulizer adapted for infants (particles diameter of 2-2.5 µm), or with a mesh-nebulizer adapted for infants (particles diameter of 2-2.5 µm).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 28 Days 至 18 Months（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Infant of less than 18 months old
- •infant hospitalized for a 1st episode of bronchiolitis defined as a 1st episode of respiratory difficulty with sibilant and\or crépitants in a viral context (head cold and\or cough and\or fever and\or notion of contage)
- •Necessity of an clinical score upper to
- •This clinical score, described by Wang in 1992, is the clinical score classically used in the studies concerning the acute(sharp) bronchiolitis of the infant ( 8,9,12 ). He(it) is at most on 12 points.
- •absence of respiratory décompensation requiring an admission in Unity of Pediatric Intensive care
- •signature of the Informed consent
- •Membership in a national insurance
排除标准
- •Refusal of the parents to participate in the study
- •18-month-old infant hospitalized for acute(sharp) bronchiolitis with a clinical score lower than
- •signs of respiratory décompensation requiring a transfer in resuscitation, signs of hypercapnie or episodes of apneas
- •histories of bronchiolitis or asthma of the infant
- •cardiac underlying pathology, respiratory, neuromuscular, immunodeficient or former premature of less of 34 weeks of amenorrhoea and less than 3 months of corrected age.
- •child having set within 6 hours preceding the inclusion a treatment by bronchodilatateurs or corticoids by systematic or inhaled way.
结局指标
主要结局
the improvement of the clinical score of severity at the 48th hour between the 3 groups of children
时间窗: 12 months
次要结局
- tolerance of the nebulisations(12 months)
- the number of children requiring oxygen(12 months)
- the number of complications.(12 months)
- the number of parenteral nutrition(12 months)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101)AsthmaNCT00306163AstraZeneca37
已完成
不适用
High Flow in Infants With BronchiolitisBronchiolitisNCT02913040Princess Amalia Children's Clinic111
已完成
不适用
In-Vivo Evaluation of Nebulized Aerosols Delivered Via Nasal RouteInterface Acceptance During Delivery of Aerosol Medicine to an Infant or ChildNCT02082379Arkansas Children's Hospital Research Institute21
已完成
不适用
The Effect of Playing With a Toy Nebulizer and Watching Cartoons on the Fear and Anxiety on ChildrenFearInhalant UseAnxietyNCT06339112Tarsus University114
已完成
3 期
Efficacy and Safety of Resveratrol and Carbossimetyl Beta Glucan in Treatment of Upper Airways Disease in InfancyCommon ColdNCT03683108Policlinico Hospital100